Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000009

Chief Medical Officer acquired 53,720 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2024-01-03 Grant or award +53,720 162,434 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ho Carole Chief Medical Officer 2024-01-03 Grant or award · Stock Option (right to buy) +161,160 161,160 D: show line 2 in the form
Loading xslF345X05/wk-form4_1704495415.xml…